basocare 1000 mg enterotabletter
fresenius medical care deutschland gmbh - natriumhydrogencarbonat - enterotabletter - 1000 mg
natriumbikarbonat "sad" 500 mg enterotabletter
amgros i/s - natriumhydrogencarbonat - enterotabletter - 500 mg
samarin brusepulver, enkeltdosisbeholder
orkla care a/s - natriumhydrogencarbonat - brusepulver, enkeltdosisbeholder
tomahawk 200 ec emulsionskoncentrat
adama northern europe b.v. - fluroxypyr - emulsionskoncentrat - 200 g/l fluroxypyr
tomahawk 180 ec emulsionskoncentrat
adama northern europe b.v. - fluroxypyr - emulsionskoncentrat - 180 g/l fluroxypyr
volibris
glaxosmithkline (ireland) limited - ambrisentan - hypertension, lunge - antihypertensiva, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.
ambrisentan mylan
mylan s.a.s - ambrisentan - hypertension, lunge - antihypertensiva, - ambrisentan mylan er indiceret til behandling af pulmonal arteriel hypertension (pah) hos voksne patienter, som funktionel class (fc) ii til iii, herunder til brug i kombination behandling. effektivitet er blevet vist i idiopatisk pah (ipah) og i pah associeret med bindevævssygdom. ambrisentan mylan er indiceret til behandling af pulmonal arteriel hypertension (pah) hos voksne patienter, som funktionel class (fc) ii til iii, herunder til brug i kombination behandling. effektivitet er blevet vist i idiopatisk pah (ipah) og i pah associeret med bindevævssygdom.
sugammadex "atnahs" 100 mg/ml injektionsvæske, opløsning
atnahs pharma netherlands b.v. - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
adcirca (previously tadalafil lilly)
eli lilly nederland b.v. - tadalafil - hypertension, lunge - urologicals - adultstreatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity (see section 5. effektivitet er blevet vist i idiopatisk pah (ipah) og i pah relateret til kollagenvaskulær sygdom. paediatric populationtreatment of paediatric patients aged 2 years and above with pulmonary arterial hypertension (pah) classified as who functional class ii and iii.